| CONTENTS |
| How Nasal Delivery Can Meet the Changing Needs of Patients & the Drug Development Industry Dr Shunji Haruta, Executive Officer SNBL |
| Interview Mr Jean-Marc Pardonge, President Aptar Pharma Prescription Division |
| Dry Nasal Powders: a New Analytical Challenge? Dr Paul Kippax, Product Group Manager Malvern Instruments |
| What’s in a GSD? Dr Bob Lott, Founder CI Informatics |
| Single-Dose Inhalers for Capsules: a Consolidated Tradition with Ample Growth Prospects Mr Pierluigi Magni, Group Marketing Manager Plastiape |
| Conference Report 39th Annual Meeting & Exposition of the Controlled Release Society 2012 |
| Inhalation Manufacturing: Cold Fill, Pressure Fill, and Finding the Right Partner Ross Errington, Business Development Manager 3M Drug Delivery Systems |
| Conference Report Respiratory Drug Delivery (RDD) 2012 |
| Recombinant Human Albumin: Delivering the Future of Type 2 Diabetes Medication Dr Mark Perkins, Customer Solution Specialist Novozymes Biopharma US |